Investor Presentaiton
2000
1983
Kwality at a Glance: Evolution of the Company
2004
2010
•
Started marketing office in Africa
and new manufacturing in
Jammu (HP)
New manufacturing with OSD and
injectable capabilities for general
therapies and beta lactam
1983-2000
2000-2010
Kwality was founded with generic
liquid orals and injectables facility
Started exporting to Africa
and ASEAN countries
2015
•
2012
2010-2015
WHO approval for Amritsar facility
New facility for Anti-cancer
products
• Started exporting to gulf countries
Listing on BSE SME exchange
Libya, Ivory Coast, Nigeria
approval for Amritsar facility
5
2018
PICS/GMP from Iran, Iraq and
Tanzania
• New Cephalosporin facility in HP
2022
2015-20
2021
2020-2022
•
11 molecules registered in emerging
markets.
• WHO approval for cephalosporin unit
•
Enhanced injectables capabilities at
Amritsar facility
Developed over 10 complex
products including microspheres,
Liposomes, Ophthalmic susp. etc.View entire presentation